Chunli Medical (688236.SH) announced that on June 13, 2024, the company received a letter from the Chairman of the Board of Directors, Shi Wenling, proposing to repurchase A-shares of the company for Beijing Chunli Zhengda Medical Instruments Co., Ltd. The repurchased shares are intended to be used for the implementation of an employee stock ownership plan and/or stock-based incentives. The total amount of funds for the repurchase of shares is not less than RMB 20 million (inclusive) and not more than RMB 40 million (inclusive).
In an announcement released by Chunli Medical (688236.SH), the company stated that on June 13, 2024, it received a letter from the Chairman of the Board of Directors, Shi Wenling, proposing the repurchase of A-share stocks from the company for Beijing Chunli Zhengda Medical Instruments Co., Ltd. The repurchased stocks will be used for future employee shareholding plans and/or stock-based incentives. The total amount of funds for the repurchase of stocks is not less than 20 million yuan (inclusive) and not more than 40 million yuan (inclusive).